CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25
- Product NDC
- 49527-080
- 11-digit product format
- 495270080
- Labeler code
- 49527
- Product ID
- 49527-080_0818396d-cc21-00ac-e063-6394a90a5d82
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- TITANIUM DIOXIDE, ZINC OXIDE
- Dosage form
- LIQUID
- Route
- TOPICAL
- Labeler
- CLINIQUE LABORATORIES LLC
- Application
- M020
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-09-24
- Substance
- TITANIUM DIOXIDE; ZINC OXIDE
- Active strength
- 24; 59 mg/mL; mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 49527-080 | 49527-080-03 | D | Discontinued by firm | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-27 05:24 UTC · source 2025-02-26 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | f268b84574a6… | 26285f5ac5df… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 302b2466d912… | e7b80fea0513… |
| 2025-02-01 13:13 UTC · source 2025-01-31 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | f764e8902f78… | 92046438deef… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-17 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 68b1e3bced9e… | 98a755eb8bc6… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-29 20:42 UTC · source 2024-11-29 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 05c55d027831… | ca05dca9dc4c… | |
| 2024-11-29 20:42 UTC · source 2024-11-29 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 05c55d027831… | ca05dca9dc4c… |
| 2024-11-09 02:36 UTC · source 2024-11-08 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 48b4f40e6753… | c7c7a00d2afa… | |
| 2024-11-09 02:36 UTC · source 2024-11-08 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 48b4f40e6753… | c7c7a00d2afa… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-09 02:27 UTC · source 2024-10-08 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 27f29a85d7e4… | 1372111e901f… | |
| 2024-10-09 02:27 UTC · source 2024-10-08 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 27f29a85d7e4… | 1372111e901f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 8d62ce987f31… | 9fe9ef23e30d… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 8d62ce987f31… | 9fe9ef23e30d… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:11 UTC · source 2024-05-28 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | d1e113ab4d42… | 063ee3eb0a1d… | |
| 2024-05-28 21:11 UTC · source 2024-05-28 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | d1e113ab4d42… | 063ee3eb0a1d… |
| 2024-05-15 03:51 UTC · source 2024-05-14 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 50b4072663b7… | eae3003ed65e… | |
| 2024-05-15 03:51 UTC · source 2024-05-14 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 50b4072663b7… | eae3003ed65e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TITANIUM DIOXIDE | 24 mg/mL |
| ZINC OXIDE | 59 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 15FIX9V2JP | Internal UNII lookup |
| SOI2LOH54Z | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 884abba1-891d-4c3c-b203-38a5a8a57756 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49527-080-01 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 30 mL in 1 BOTTLE | LIQUID | 30 | 13 | |
| 49527-080-01 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 1 in 1 CARTON | LIQUID | 1 | 13 | |
| 49527-080-02 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 1 in 1 CARTON | LIQUID | 1 | 13 | |
| 49527-080-02 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 5 mL in 1 TUBE | LIQUID | 5 | 13 | |
| 49527-080-03 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 0.2 mL in 1 PACKET | LIQUID | 0.2 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49527-080 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 (TITANIUM DIOXIDE, ZINC OXIDE) LIQUID [CLINIQUE LABORATORIES LLC] | 13 | Current NDC, Legacy NDC, 5 package rows | 20231020_884abba1-891d-4c3c-b203-38a5a8a57756.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bath and Body Works SPF At The Beach | AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE | Bath & Body Works, Inc. | 1c315bdb-dc33-1737-e063-6294a90a31a4 | 2026-03-02 | Warnings | M020 |
| Bath and Body Works SPF Tahiti Isle | AVOBENZONE,HOMOSALATE,OCTISALATE,OCTOCRYLENE | Bath & Body Works, Inc. | 38d02c8d-cdc8-b8d6-e063-6294a90ad9e4 | 2026-03-02 | Warnings | M020 |
| Sport | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTISALATE | Old East Main Co. | a460e512-f268-4941-beb6-29df10fdbb3a | 2026-03-02 | Warnings, Adverse reactions | M020 |
| Tanning Sunscreen SPF 15 | AVOBENZONE HOMOSALATE OCTISALATE | Old East Main Co. | 42258ebe-e3cc-4d70-e063-6294a90a9651 | 2026-03-02 | Warnings, Adverse reactions | M020 |
| SUNSCREEN | AVOBENZONE, HOMOSALATE, OCTISALAT, OCTOCRYLENE | Old East Main Co. | db876d34-1af9-4e0a-9e9a-32a8b00e9405 | 2026-03-02 | Warnings, Adverse reactions | M020 |
| Sunscreen | AVOBENZONE, HOMOSALATE,OTISALATE, OCTOCRYLENE | Old East Main Co. | 2ea288fe-815d-4568-9592-55ea428448fa | 2026-03-02 | Warnings, Adverse reactions | M020 |
| Avobenzone, Homosalate, Octisalate | AVOBENZONE, HOMOSALATE, OCTISALATE | Old East Main Co. | cea1c223-c9d4-42ac-8c5b-c0ca647d57a1 | 2026-03-02 | Warnings, Adverse reactions | M020 |
| sunscreen | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | Old East Main Co. | 00ee1dc6-b4f3-4ae3-890c-8e37f6d3fe3a | 2026-03-02 | Warnings, Adverse reactions | M020 |
| Avobenzone, Homosalate, Octisalate | AVOBENZONE, HOMOSALATE, OCTISALATE | Old East Main Co. | 8f4a6a31-2fae-42fe-924f-10237c59e791 | 2026-03-02 | Warnings, Adverse reactions | M020 |
| Avobenzone, Homosalate, Octisalate | AVOBENZONE, HOMOSALATE, OCTISALATE | Old East Main Co. | ef48288b-533f-4924-ba12-fc8cb83643d4 | 2026-03-02 | Warnings | M020 |
| Avobenzone, Homosalate, Octisalate | AVOBENZONE, HOMOSALATE, OCTISALATE | Old East Main Co. | e6976bf4-ad77-4953-858f-4a0ec7f4300c | 2026-03-02 | Warnings, Adverse reactions | M020 |
| Avobenzone, Homosalate, Octisalate | AVOBENZONE, HOMOSALATE, OCTISALATE | Old East Main Co. | b3d2da09-d9c9-4c27-82fe-a434ece2f099 | 2026-03-02 | Warnings, Adverse reactions | M020 |
| Avobenzone, Homosalate, Octisalate | AVOBENZONE, HOMOSALATE, OCTISALATE | Old East Main Co. | ba9331ef-3744-4072-80a2-af95c6f7ee05 | 2026-03-02 | Warnings, Adverse reactions | M020 |
| Avobenzone, Homosalate, Octisalate | AVOBENZONE, HOMOSALATE, OCTISALATE | Old East Main Co. | 4a0cab2d-3c73-4b0b-b0c4-f72b1a0de1cf | 2026-03-02 | Warnings, Adverse reactions | M020 |
| Avobenzone, Homosalate, Octisalate | AVOBENZONE, HOMOSALATE, OCTISALATE | Old East Main Co. | 1a53d8d5-e650-4825-8a3b-7cf42c36e3e5 | 2026-03-02 | Warnings, Adverse reactions | M020 |
| Avobenzone, Homosalate, Octisalate | AVOBENZONE, HOMOSALATE, OCTISALATE | Old East Main Co. | 086dfda5-9fe7-46b4-9964-4977b86cfdd5 | 2026-03-02 | Warnings, Adverse reactions | M020 |
| Avobenzone, Homosalate, Octisalate | AVOBENZONE, HOMOSALATE, OCTISALATE | Old East Main Co. | ce9a2139-c5c2-43e2-bd51-1f14ace594d9 | 2026-03-02 | Warnings, Adverse reactions | M020 |
| Bask SPF 40 Broad Spectrum | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | Surfside Skincare, Inc. dba Bask Suncare | 49a30877-e39f-46a3-e063-6394a90a8dd2 | 2026-03-02 | Warnings | M020 |
| Sunscreen SPF30 | AVOBENZONE 3% HOMOSALATE 10% OCTOCRYLENE 5% | Worthy Promotional Products | f6014a97-12d3-4f42-86de-866a206c6c06 | 2026-03-02 | Warnings | M020 |
| 2000DL-CL30V | SPF30 BS VANILLA | Epic Laboratories, LLC | 02488aad-28be-4ffb-e063-6294a90ad01e | 2026-03-02 | Warnings | M020 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 49527-080-01 | 49527008001 | 1 BOTTLE in 1 CARTON (49527-080-01) / 30 mL in 1 BOTTLE | 1 bottle | 2020-09-24 | 0000-00-00 | No | No | Current |
| 49527-080-02 | 49527008002 | 1 TUBE in 1 CARTON (49527-080-02) / 5 mL in 1 TUBE | 1 tube | 2022-06-06 | 0000-00-00 | No | No | Current |
| 49527-080-03 | 49527008003 | .2 mL in 1 PACKET (49527-080-03) | 2022-11-30 | 0000-00-00 | Yes | No | Current |